CRM vs CRWV: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and CoreWeave, Inc. Class A Common Stock β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
Salesforce, Inc. Β· Technology
$236.42
+11.6% upside to fair value
Med Conviction Grade B High Quality
VS
CoreWeave, Inc. Class A Common Stock Β· Technology
$86.76
+45.0% upside to fair value
Med Conviction Grade B
QuantHub Verdict
CRWV has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRM CRWV
Current Price $236.42 $86.76
Fair Value Estimate $263.88 $125.80
Upside to Fair Value +11.6% +45.0%
Market Cap $193.6B $47.3B
Forward P/E β€” β€”
EV / EBITDA 14.4x 36.3x
Price / Sales 4.4x 6.2x
Price / FCF 12.8x β€”
Revenue Growth YoY +10.8% +112.3%
Gross Margin 77.3% 67.4%
Operating Margin 21.4% -3.0%
Return on Equity 20.2% -45.4%
Dividend Yield 0.73% 0%
FCF Yield 7.82% β€”
Analyst Consensus Buy Buy
Investment Thesis
CRM β€” Salesforce, Inc.
Salesforce is the leading enterprise customer relationship management platform, spanning Sales, Service, Platform, Marketing, Commerce, Tableau, MuleSoft, and Slack under the Customer 360 umbrella, with 83,334 employees and a business that converts $53.65 of revenue per share into $18.48 of free cash flow per share. Business quality is high: TTM gross margin of 77.3%, TTM operating margin of 21.4…
CRWV β€” CoreWeave, Inc. Class A Common Stock
CoreWeave operates a specialized GPU cloud platform purpose-built for generative AI workloads, offering high-performance GPU and CPU compute, storage, networking, and managed services to large enterprises from bare-metal and virtual server options. The business is growing explosively, with revenue up 112.3% year over year in the most recent quarter and a TTM gross margin of 67.4%, but it is doing…
Accumulation Zones
Metric CRM CRWV
Zone Low $197.91 $94.35
Zone High $224.30 $106.93
In Buy Zone? No Yes
← CRM Research    CRWV Research β†’    All Research